CORC

在结果中检索

CORC

浏览/检索结果: 共101条，第1-10条 帮助

已选(0)清除 条数/页：   排序方式：
Treating relapsed/refractory mature T- and NK-cell neoplasms with tislelizumab: a multicenter open-label phase 2 study 期刊论文
BLOOD ADVANCES, 2023, 卷号: 7
作者:  Bachy, Emmanuel;  Savage, Kerry J.;  Huang, Huiqiang;  Kwong, Yok-Lam;  Gritti, Giuseppe
收藏  |  浏览/下载：14/0  |  提交时间：2023/11/10
Tislelizumab, a PD-1 inhibitor for relapsed/refractory mature T/NK-cell neoplasms: Results from a phase 2 study. 期刊论文
JOURNAL OF CLINICAL ONCOLOGY, 2022, 卷号: 40
作者:  Bachy, Emmanuel;  Savage, Kerry J.;  Huang, Huiqiang;  Kwong, Yok-Lam;  Gritti, Giuseppe
收藏  |  浏览/下载：19/0  |  提交时间：2022/12/23
Efficacy and Safety of Recombinant Human-Mouse Chimeric Anti-CD20 Monoclonal Antibody (SCT400) Combined with CHOP in Patients with Treatment-Naive Diffuse Large B-Cell Lymphoma: A Multicenter, Randomized, Single-Blind, Parallel Active-Controlled, Phase III Study 期刊论文
BLOOD, 2021, 卷号: 138
作者:  Shi, Yuankai;  Zhang, Qing Yuan;  Hong, Xiaonan;  Wang, Zhen;  Gao, Yuhuan
收藏  |  浏览/下载：13/0  |  提交时间：2022/12/23
Safety and activity of sintilimab in patients with relapsed or refractory classical Hodgkin lymphoma (ORIENT-1): a multicentre, single-arm, phase 2 trial 期刊论文
LANCET HAEMATOLOGY, 2019, 卷号: 6, 期号: 1
作者:  Zhang, Wei;  Gao, Yuhuan;  Jin, Zhengming;  Zhou, Jianfeng;  Jin, Chuan
收藏  |  浏览/下载：46/0  |  提交时间：2019/12/05
Design and synthesis of various quinizarin derivatives as potential anticancer agents in acute T lymphoblastic leukemia 期刊论文
BIOORGANIC & MEDICINAL CHEMISTRY, 2019, 卷号: 27, 页码: 1362-1369
作者:  Hu, Xiufang;  Cao, Yanqin;  Yin, Xu;  Zhu, Li;  Chen, Yingyu
收藏  |  浏览/下载：18/0  |  提交时间：2019/11/21
Clinical risk score for invasive fungal diseases in patients with hematological malignancies undergoing chemotherapy: China Assessment of Antifungal Therapy in Hematological Diseases study. 期刊论文
Frontiers of medicine, 2019
作者:  Wang Ling;  Wang Ying;  Hu Jiong;  Sun Yuqian;  Huang He
收藏  |  浏览/下载：9/0  |  提交时间：2019/12/13
A single-arm, multicenter, phase 2 study of camrelizumab in relapsed or refractory classical Hodgkin lymphoma 期刊论文
2019
作者:  Song Yuqin;  Wu Jianqiu;  Chen Xinchuan;  Lin Tong-Yu;  Cao Junning
收藏  |  浏览/下载：26/0  |  提交时间：2020/01/03
Four-year follow-up of patients with imatinib-resistant or intolerant chronic myeloid leukemia receiving dasatinib: efficacy and safety 期刊论文
2019, 卷号: 13, 期号: 3, 页码: 344-353
作者:  Huang, Xiaojun;  Jiang, Qian;  Hu, Jianda;  Li, Jianyong;  Jin, Jie
收藏  |  浏览/下载：15/0  |  提交时间：2020/01/03
Safety and activity of sintilimab in patients with relapsed or refractory classical Hodgkin lymphoma (ORIENT-1): a multicentre, single-arm, phase 2 trial 期刊论文
2019, 卷号: 6, 期号: 1, 页码: E12-E19
作者:  Shi, Yuankai;  Su, Hang;  Song, Yongping;  Jiang, Wenqi;  Sun, Xiuhua
收藏  |  浏览/下载：19/0  |  提交时间：2020/01/03
Effectiveness and Tolerability of Micafungin in Chinese Patients with Invasive Fungal Infections: A Retrospective, Multicenter Study 期刊论文
ADVANCES IN THERAPY, 2018, 卷号: 35, 期号: 9
作者:  Zheng, Xiaoyun;  Huang, Xiaobo;  Luo, Jianmin;  Li, Juan;  Li, Wei
收藏  |  浏览/下载：7/0  |  提交时间：2019/12/05

©版权所有 ©2017 CSpace - Powered by CSpace